Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Cord blood cells improve islet transplantation outcomes

Jan. 21, 2020

Oncogenic FHL2-GLI2 fusion identified in sclerosing stromal tumors of the ovary

Jan. 17, 2020

Vertex's VX-814 enters phase II development for alpha1-antitrypsin deficiency

Jan. 16, 2020

New PCSK9 inhibitors discovered at Ra Pharmaceuticals

Jan. 16, 2020

European Commission grants marketing authorization for Isturisa

Jan. 16, 2020

Cts Biopharma describes new anti-marinobufagenin antibodies

Jan. 15, 2020

Zuclomiphene reduces moderate to severe hot flashes in men with prostate cancer on ADT

Jan. 15, 2020

Topline data presented from TRILOGY 1 study of CaPre

Jan. 14, 2020

BioMarin to initiate clinical testing of BMN-307 gene therapy

Jan. 14, 2020

MRAP2 is accessory after the fact for appetite regulation

Jan. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...